サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1567795

北米のニキビ治療薬：2030年市場予測- 地域別分析- 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別

North America Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

出版日
ページ情報
英文 121 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
北米のニキビ治療薬：2030年市場予測- 地域別分析- 治療クラス、剤形、タイプ、ニキビタイプ、流通チャネル別
出版日: 2024年08月07日
発行: The Insight Partners
ページ情報: 英文 121 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のニキビ治療薬市場は、2022年に33億6,250万米ドルと評価され、2030年には47億9,401万米ドルに達すると予測され、2023年から2030年までのCAGRは4.6%と推定されます。

オーガニック・ナチュラル治療へのニーズの高まりが北米のニキビ治療薬市場を活性化

従来のスキンケア製品に使用されている合成成分や化学物質が有害な影響を及ぼす可能性があることへの意識が高まるにつれ、より安全で優しく、環境に優しいとされる天然素材やオーガニックの代替品への需要が世界中で高まっています。消費者は、刺激の強い化学物質や人工香料、潜在的な刺激物質を含まない製品をますます求めるようになり、植物由来成分、植物エキス、エッセンシャルオイル、その他スキンケア効果で知られる天然化合物の力を活用した処方を選ぶようになっています。こうした動向を受け、多くのスキンケア・ブランドやメーカーが、健康志向の消費者のニーズに応えるべく、ナチュラルでオーガニックなニキビ治療製品を幅広く開発しています。これらの製品には、ティーツリーオイル、ウィッチヘーゼル、アロエベラ、緑茶エキス、サリチル酸など、天然由来の成分が配合されていることが多く、効能を損なうことなく、よりホリスティックで持続可能なアプローチでニキビを治療することができます。2022年7月、オーガニックスキンケア事業を展開するMADARAは、微生物バランスを整えるモイスチャライザーと、乾燥しない洗顔料という、2つの新しいナチュラルな日常用スキンケア製品を発表しました。同社は、これらの製品は科学と自然を融合して開発され、ニキビができやすいさまざまな顔色の人々にやさしくケアできるよう特別に処方されたとしています。どちらの製品も、ノーザン・ジュニパー幹細胞、発酵多糖類、地衣類とマテ茶の抽出物といった、天然、オーガニック、ヴィーガンの成分で作られており、肌を傷つけず、欠点に特化して対処します。大人もティーンエイジャーもこの製品を利用できます。このように、自然でオーガニックなニキビ治療オプションへの嗜好の高まりは、今後数年間、北米のニキビ治療薬市場の将来を形成し続けると予想されます。

天然およびオーガニックのニキビ治療オプションへのシフトは、規制当局の監視の厳しさと業界標準に関連する合併症の増加によっても推進されています。規制機関は成分の透明性、安全性、持続可能性を重視しており、企業はよりクリーンで環境に優しいスキンケア解決策を求める消費者の嗜好の進化に合わせて製品を改良するよう促されています。このように、スキンケアのルーチンにおいて天然成分や環境に優しい処方を優先する消費者が増えるにつれて、北米のニキビ治療薬市場は今後数年間で新たな成長動向を経験することが予想されます。

北米のニキビ薬市場概要

北米のニキビ治療薬市場は、米国、カナダ、メキシコに区分されます。2022年の北米のニキビ治療薬市場シェアは米国が最大でした。ニキビは、ゴミ、油、皮脂、死んだ皮膚細胞が毛包に詰まることによって引き起こされる皮膚疾患です。米国皮膚科学会によると、ニキビは米国で最も蔓延している病気で、毎年5,000万人もの米国人がニキビに苦しんでいます。アメリカ人のニキビ発生率の増加と、それに伴う様々な革新的なニキビ治療薬の発売により、この国のニキビ治療薬市場は拡大すると予測されています。

北米のニキビ治療薬市場の収益と2030年までの予測（金額）

北米のニキビ治療薬市場セグメンテーション

北米のニキビ治療薬市場は、治療クラス、製剤、タイプ、ニキビタイプ、流通チャネル、国に基づいてセグメント化されます。

治療クラスに基づき、北米のニキビ治療薬市場はレチノイド、過酸化ベンゾイル、抗生物質、サリチル酸、その他に区分されます。2022年にはレチノイドセグメントが最大のシェアを占めています。

製剤面では、北米のニキビ治療薬市場は外用薬と内服薬に二分されます。外用薬セグメントは2022年に最大のシェアを占めました。

タイプ別では、北米のニキビ治療薬市場は処方薬と市販薬に二分されます。2022年には、処方薬セグメントがより大きな最大シェアを占めました。

ニキビタイプ別に見ると、北米のニキビ治療薬市場は非炎症性ニキビと炎症性ニキビに二分されます。2022年には炎症性ニキビセグメントがより大きなシェアを占めています。

流通チャネルの面では、北米のニキビ治療薬市場は薬局・薬店、小売店、eコマースに区分されます。薬局・薬店セグメントが2022年に最も大きなシェアを占めました。

国別では、北米のニキビ治療薬市場は米国、カナダ、メキシコに分類されます。2022年の北米のニキビ治療薬市場は米国が支配的でした。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、Johnson &Johnson、Bausch Health Companies Inc、Centro Internacional de Cosmiatria SA de CV、Galderma SA、Pfizer Inc、GSK Plc、Viatris Inc、Somar Sapi De CV、Italmex SAは、北米のニキビ治療薬市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 北米のニキビ治療薬市場情勢

  • PEST分析
  • 外用薬と経口薬の価格分析
  • ニキビ治療を受ける患者層

第5章 北米のニキビ治療薬市場：主要市場力学

  • 主要市場促進要因
    • 重症ニキビの有病率の増加
    • 新薬の上市
  • 主な市場抑制要因
    • ニキビ治療薬に伴う副作用
  • 主な市場機会
    • 最先端技術とデータ主導型戦略に基づく個別化治療プログラム
  • 今後の動向
    • オーガニック・ナチュラル治療へのニーズの高まり
  • 促進要因と抑制要因の影響

第6章 ニキビ治療薬市場-北米市場分析

第7章 ニキビ治療薬の北米市場分析-治療クラス別

  • レチノイド
  • 過酸化ベンゾイル
  • 抗生物質
  • サリチル酸
  • その他

第8章 北米のニキビ治療薬市場分析-剤形別

  • 外用薬
  • 経口薬

第9章 北米のニキビ治療薬市場分析-タイプ別

  • 処方薬
  • 市販薬

第10章 北米のニキビ治療薬市場分析-ニキビタイプ別

  • 非炎症性ニキビ
  • 炎症性ニキビ

第11章 北米のニキビ治療薬市場分析-流通チャネル別

  • 薬局・ドラッグストア
  • 小売店
  • eコマース

第12章 北米のニキビ治療薬市場：国別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ

第13章 ニキビ治療薬市場-業界情勢

  • ニキビ治療薬市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
  • ファルマピエルと他社ニキビ治療薬の製品比較

第14章 企業プロファイル

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Centro Internacional de Cosmiatria SA de CV
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Somar Sapi De CV
  • Italmex SA

第15章 付録

図表

List Of Tables

  • Table 1. North America Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Recent Organic Growth Strategies in Acne Medication Market
  • Table 27. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 28. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. North America Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Acne Medication Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Acne Medication Market Revenue (US$ Million), 2020-2030
  • Figure 6. North America Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 7. Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 13. Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 16. Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. North America Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 19. Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 22. Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 26. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Growth Strategies in Acne Medication Market
目次
Product Code: BMIRE00030656

The North America acne medication market was valued at US$ 3,362.50 million in 2022 and is expected to reach US$ 4,794.01 million by 2030; it is estimated to register at a CAGR of 4.6% from 2023 to 2030.

Upsurge in Need for Organic and Natural Treatments Fuels North America Acne Medication Market

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MADARA, an organic skincare business, introduced two new and natural everyday skincare products-a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature, and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients-Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Mate tea extracts-which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the North America acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the North America acne medication market is expected to experience new growth trends in the coming years.

North America Acne Medication Market Overview

The acne medication market in North America is segmented into the US, Canada, and Mexico. The US held the largest North American acne medication market share in 2022. Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications.

North America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

North America Acne Medication Market Segmentation

The North America acne medication market is segmented based on therapeutic class, formulation, type, acne type, and distribution channel, and country.

Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the North America acne medication market is categorized into US, Canada, and Mexico. The US dominated the North America acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA are some of the leading companies operating in the North America acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. North America Acne Medication Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Severe Acne
    • 5.1.2 Launch of Novel Drugs
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects Associated with Acne Medication
  • 5.3 Key Market Opportunities
    • 5.3.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.4 Future Trends
    • 5.4.1 Upsurge in Need for Organic and Natural Treatments
  • 5.5 Impact of Drivers and Restraints:

6. Acne Medication Market - North America Market Analysis

7. North America Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. North America Acne Medication Market - Country Analysis

  • 12.1 North America
    • 12.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 US
      • 12.1.1.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 US: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 US: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 US: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Canada
      • 12.1.1.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Canada: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Canada: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 Mexico
      • 12.1.1.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 Mexico: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Almirall SA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson & Johnson
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sun Pharmaceutical Industries Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Bausch Health Companies Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Centro Internacional de Cosmiatria SA de CV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Somar Sapi De CV
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 Italmex SA
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms